Motor Function Is Associated with Cerebral Small Vessel Disease and Can Predict Mortality and Poor Functional Outcome
Cerebrovascular Diseases · 2024
DOI: 10.1159/000540639 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Cerebrovascular Diseases, 2024. Verfasst von Megumi Hosoya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Cerebral Small Vessel Diseases, Motor Disorders, Motor Activity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Introduction
The primary objective of this study was to elucidate the predictive role of subtle motor impairment evaluated using the Unified Parkinson’s Disease Rating Scale (UPDRS) Part III on mortality and functional outcome. The secondary objective was to evaluate the association of motor impairment with small vessel disease (SVD) severity.
Methods
We derived data from a Japanese cohort of patients with evidence of SVD who were enrolled from 2015 to 2019, and followed until 2023. The present study included 586 participants who agreed for UPDRS Part III evaluation. The severity of white matter hyperintensities (WMHs) and the presence of lacunes were evaluated. Cox proportional hazard models and multiple logistic regression analysis were used to examine the association between UPDRS Part III score and all-cause death and functional outcome defined by the modified Rankin Scale (mRS) score at the last visit, respectively.
Results
The median age was 71 years, and the median UPDRS Part III score was 2. The UPDRS Part III score was associated with the severity of WMH (r = 0.225, p < 0.001) and the number (0, 1, ≥2) of lacunes (p < 0.001). During a mean follow-up period of 4.8 years, 29 patients died. The Cox proportional hazard analysis revealed that high UPDRS Part III scores (≥5) were associated with a higher risk of all-cause death compared to low (score 0) and middle (score 1–4) scores (adjusted hazard ratio 3.04; 95% confidence interval, 1.50–7.34, p = 0.005). In multivariate logistic analysis, high UPDRS Part III scores were associated with poor functional outcome (mRS of ≥3) compared with low and middle scores after adjusting for confounding factors (adjusted odds ratio 1.86; 95% confidence interval 1.02–3.41, p = 0.043).
Conclusions
Subtle motor impairment was associated with the severity of WMH and number of lacunes and could predict mortality and poor functional outcome independently of vascular risk factors and severity of WMH and lacunes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
- Department of Medicine, Tokyo Women's Medical University, Adachi Medical Center, Tokyo, Japan.
- Department of Public Health, Tokyo Women's Medical University, Tokyo, Japan.
- Graduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka, Japan.
- Department of Neurology, Tokyo Women's Medical University, Yachiyo Medical Center, Yachiyo, Japan.
- Department of Neurology, Suita Municipal Hospital, Suita, Japan.
Zitieren
APA
Hosoya, M., Toi, S., Seki, M., Hoshino, T., Sato, Y., Yoshizawa, H., Iijima, M., & Kitagawa, K. (2024). Motor Function Is Associated with Cerebral Small Vessel Disease and Can Predict Mortality and Poor Functional Outcome. Cerebrovascular Diseases. https://doi.org/10.1159/000540639
Vancouver
Hosoya M, Toi S, Seki M, Hoshino T, Sato Y, Yoshizawa H, et al. Motor Function Is Associated with Cerebral Small Vessel Disease and Can Predict Mortality and Poor Functional Outcome. Cerebrovascular Diseases. 2024. doi:10.1159/000540639
BibTeX
@article{Hosoya2024,
author = {Hosoya, Megumi and Toi, Sono and Seki, Misa and Hoshino, Takao and Sato, Yasuto and Yoshizawa, Hiroshi and Iijima, Mutsumi and Kitagawa, Kazuo},
title = {Motor Function Is Associated with Cerebral Small Vessel Disease and Can Predict Mortality and Poor Functional Outcome},
journal = {Cerebrovascular Diseases},
year = {2024},
doi = {10.1159/000540639}
}
EUVIMED